The International Multiple Sclerosis Management Practice (IMSMP) is a world leading center for the care and treatment of people with multiple sclerosis. The most comprehensive multidisciplinary MS team is assembled to provide the best level of care for our patients.
Specializing in MS imaging our new MRI Suite is an extension of your doctor's office. Have your scheduled MRI performed and then be escorted down the hall for your office visit. Your neurologist will be able to immediately read and review your MRI.
The entire staff at the IMSMP are involved in managing your care. From morning meetings, outlining the day, to the physician conferences in which patients are discussed with the group of neurologists, the team approach is our philosophy.
The Tisch MSRCNY Phase I Clinical Stem Cell Trial was featured on the CBS Evening News on Monday, January 20th. For those of you who missed the segment, CBS has posted the video and a text article on the study and its approval. Please share the link with all of your family and friends.
FDA Approves Stem Cell Trial at Tisch MS Research Center
The Tisch MS Research Center of New York has received approval from the Food and Drug Administration (FDA) to commence a Phase 1 trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). This study will attempt to repair the damage caused by MS. (pictured above: Dr. Saud A. Sadiq and Dr. Violaine K. Harris)
Dr. Saud Sadiq Speaks at the Vatican on Stem Cell Research
Dr. Sadiq presented years of stem cell research from the Tisch MS Research Center of New York during the Second International Adult Stem Cell Conference held at the Vatican April 11-13, 2013. Cardinal Gianfranco Ravasi (pictured center) and hundreds of others gathered to hear the presentation.
We are pleased to announce, Dr. Saud A. Sadiq, Director of the International Multiple Sclerosis Management Practice (IMSMP) and Tisch MS Research Center of New York (Tisch MSRCNY) has been elected a...